AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER
Sep 162014
 

 

 

An automated flow-based synthesis of imatinib: the API of gleevec 

M.D. Hopkin, I.R. Baxendale, S.V. Ley, J.C.S. Chem. Commun.2010, 46, 2450-2452.

http://pubs.rsc.org/en/Content/ArticleLanding/2010/CC/c001550d#!divAbstract

A concise, flow-based synthesis of Imatinib, a compound used for the treatment of chronic myeloid leukaemia, is described whereby all steps are conducted in tubular flow coils or cartridges packed with reagents or scavengers to effect clean product formation.

An in-linesolvent switching procedure was developed enabling the procedure to be performed with limited manual handling of intermediates.

Graphical abstract: A flow-based synthesis of Imatinib: the API of Gleevec

 

see supp info

http://www.rsc.org/suppdata/cc/c0/c001550d/c001550d.pdf

 

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: